fda update on tirzepatide Says Compounded Must Exit the Market FDA Approves Tirzepatide (Zepbound) as

Taking these medications with Wegovy can increase the risk of hypoglycemia

The clinical concern is not about drug testing but about gastroparesis risk: semaglutide slows gastric emptying, which can increase aspiration risk under general anesthesia if fasting protocols are not appropriately extended

Records of previous attempts at weight loss, including any supervised diets, exercise programs, or other medical treatments you've tried

Anti-inflammatory Effects: Glutathione has natural anti-inflammatory properties that serve to alleviate redness, inflammation, and irritation of skin affected by spots

The FDA notes it has collected reports of compounded GLP-1s not being refrigerated adequately or being made with poor-quality ingredients

Third-Party Peptide Testing: Preference for pharmacies providing HPLC purity and endotoxin testing results per batch